Taiwan’s biopharma sector steps into spotlight with rush of IPOs

Taipei fosters growth to support economy, security alongside semiconductors A lab where Taiwan Bio-Manufacturing Corp. conducts process analysis and development for biopharmaceutical products. (TBMC) TOKYO — Taiwan's biopharmaceutical sector is growing, with seven companies going public in the first half of 2026, helped by the government's push to nurture the next strategic industries after semiconductors.

Read the full article at the source →